EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unveiling the Cardioprotective Potential of Hydroxytyrosol: Insights from an Acute Myocardial Infarction Model

Alejandra Bermúdez-Oria iD, Eugenia Godoy iD, Virginia Pérez iD, Camila Musci Ferrari, Martin Donato iD, Juan Fernández-Bolaños iD, Tamara Zaobornyj iD, Verónica D'Annunzio

Antioxidants · 28.06.2025 · 14 (7) · 803

DOI: 10.3390/antiox14070803 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 28.06.2025. Verfasst von Alejandra Bermúdez-Oria und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Phytochemistry, Instituto de la Grasa (Spanish National Research Council, CSIC), Ctra. de Utrera km. 1, Pablo de Olavide Universit…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was supported by the "Becas Iberoamérica. Santander Investigación" program (2020-2021), funded by Banco Santander, and the José Castillejo Mobili…, Banco Santander, and the José Castillejo Mobility Grant for Young Researchers (2022), Spanish Ministry of Universities (MUNI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases remain the leading cause of death worldwide, highlighting the urgent need for novel therapeutic strategies. The Mediterranean diet is renowned for its cardiovascular benefits, largely attributed to extra virgin olive oil (EVOO) and its phenolic compounds, particularly hydroxytyrosol (HT). HT, a potent antioxidant and anti-inflammatory agent, has demonstrated significant therapeutic potential in mitigating myocardial damage following acute myocardial infarction (AMI). However, there is a notable lack of published evidence regarding the effects of HT administration in the context of acute ischemia/reperfusion (I/R) injury, making this study a novel contribution to the field. This study aimed to evaluate the cardioprotective effects of HT using the Langendorff technique in an isolated mouse heart ischemia/reperfusion (I/R) model. Mice were administered a single intraperitoneal dose of HT (10 mg/kg) 24 h prior to the I/R protocols, and parameters such as the infarct size, mitochondrial function, and redox balance were assessed. The results revealed a remarkable 57% reduction in infarct size in HT-treated mice compared to untreated controls. HT treatment also improved mitochondrial bioenergetics, as evidenced by the increased membrane potential (ΔΨm), enhanced oxygen consumption, and reduced hydrogen peroxide (H2O2) production. Furthermore, HT restored the activity of the mitochondrial respiratory complexes, notably Complex I, even under I/R conditions. These findings highlight the efficacy of HT in reducing oxidative stress and preserving mitochondrial function, critical factors in cardiac disease. In conclusion, HT emerges as a promising therapeutic agent for ischemic heart disease, demonstrating both preventive and restorative potential. Future research should explore its clinical applicability to advance cardiovascular disease management.

Schlagwörter

Stichwörter der Autor:innen

antioxidantby-productscardioprotectionhydroxytyrosol (HT)ischemic heart disease (IHD)mitochondrial function

Autor:innen und Institutionen

  • Department of Food Phytochemistry, Instituto de la Grasa (Spanish National Research Council, CSIC), Ctra. de Utrera km. 1, Pablo de Olavide University Campus, Building 46, 41013 Seville, Spain.
  • Facultad de Farmacia y Bioquímica, Instituto de Bioquimica y Medicina Prof. Alberto Boveris (IBIMOL, UBA-CONICET), Universidad de Buenos Aires, Buenos Aires 1113, Argentina.
  • Facultad de Medicina, Departamento de Patología-Instituto de Fisiopatología Cardiovascular, Universidad de Buenos Aires, Buenos Aires 1113, Argentina.

ORCID-Profile: Alejandra Bermúdez-Oria, Eugenia Godoy, Virginia Pérez, Martin Donato, Juan Fernández-Bolaños, Tamara Zaobornyj

Förderung

  • This research was supported by the "Becas Iberoamérica. Santander Investigación" program (2020-2021), funded by Banco Santander, and the José Castillejo Mobili…
  • Banco Santander, and the José Castillejo Mobility Grant for Young Researchers (2022)
  • Spanish Ministry of Universities (MUNI)

Zitieren

APA

Bermúdez-Oria, A., Godoy, E., Pérez, V., Musci Ferrari, C., Donato, M., Fernández-Bolaños, J., Zaobornyj, T., & D'Annunzio, V. (2025). Unveiling the Cardioprotective Potential of Hydroxytyrosol: Insights from an Acute Myocardial Infarction Model. Antioxidants, 14(7), 803. https://doi.org/10.3390/antiox14070803

Vancouver

Bermúdez-Oria A, Godoy E, Pérez V, Musci Ferrari C, Donato M, Fernández-Bolaños J, et al. Unveiling the Cardioprotective Potential of Hydroxytyrosol: Insights from an Acute Myocardial Infarction Model. Antioxidants. 2025;14(7):803. doi:10.3390/antiox14070803

BibTeX
@article{BermdezOria2025,
  author = {Bermúdez-Oria, Alejandra and Godoy, Eugenia and Pérez, Virginia and Musci Ferrari, Camila and Donato, Martin and Fernández-Bolaños, Juan and Zaobornyj, Tamara and D'Annunzio, Verónica},
  title = {Unveiling the Cardioprotective Potential of Hydroxytyrosol: Insights from an Acute Myocardial Infarction Model},
  journal = {Antioxidants},
  year = {2025},
  volume = {14},
  number = {7},
  pages = {803},
  doi = {10.3390/antiox14070803}
}
Kostenlos starten →